Ligand Pharmaceuticals INC
SEC CIK 886163 · LGNDD · last insider filing 2026-06-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sabba Stephen L | Director | filed 2008 - 2026 |
| Haas Jason | Director | filed 2022 - 2026 |
| Lamattina John L | Director | filed 2011 - 2026 |
| Aryeh Jason | Director | filed 2006 - 2026 |
| Kozarich John W | Director | filed 2006 - 2026 |
| Gray Nancy Ryan | Director | filed 2017 - 2026 |
| Zimmermann Martine | Director | filed 2023 - 2026 |
| Davis Todd C | Director · Chief Executive Officer | filed 2007 - 2026 |
| Higgins John L | Director · President & CEO | filed 2007 - 2022 |
| Patel Sunil | Director | filed 2010 - 2022 |
| Boyce Sarah | Director | filed 2019 - 2022 |
| Cochran Jennifer R. | Director | filed 2021 - 2022 |
| Knott David M | Director · Director | filed 2006 - 2015 |
| Burakoff Steven J | Director | filed 2008 - 2010 |
| Peacock Bruce | Director | filed 2008 - 2008 |
| Ligand Pharmaceuticals INC | Director | filed 2008 - 2008 |
| Greetham Elizabeth M | Director | filed 2007 - 2008 |
| Perry Jeffrey R | Director | filed 2006 - 2008 |
| Blissenbach Henry F | Director · President, CEO & Chairman | filed 2006 - 2007 |
| Loeb Daniel S | Director | filed 2006 - 2007 |
| Cross Alexander D | Director | filed 2006 - 2007 |
| Johnson Irving S | Director | filed 2006 - 2007 |
| Roberts Brigette | Director | filed 2006 - 2007 |
| Rocca Michael A | Director | filed 2006 - 2006 |
| Peck Carl C | Director | filed 2006 - 2006 |
| Groom John | Director | filed 2006 - 2006 |
| Robinson David E | Director · Pres, CEO & Chairman | filed 2006 - 2006 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Reardon Andrew | See Remarks | filed 2022 - 2026 |
| Espinoza Octavio | Chief Financial Officer | filed 2022 - 2026 |
| Korenberg Matthew E | VP, Finance and CFO | filed 2015 - 2024 |
| Foehr Matthew W | President and COO | filed 2011 - 2022 |
| Berkman Charles S | VP, Gen. Counsel & Secretary | filed 2007 - 2022 |
| Herman Melanie J | Interim CFO | filed 2014 - 2016 |
| Desilva Nishan M | VP, Finance & Strategy and CFO | filed 2012 - 2015 |
| Sharp John P | VP Finance and CFO | filed 2007 - 2014 |
| Kazmi Syed | VP, Bus. Dev. & Strategic Plan | filed 2007 - 2012 |
| Meglasson Martin | V-P, Discovery Research | filed 2006 - 2010 |
| Dziewanowska Zofia E | VP, Clinical Research | filed 2007 - 2009 |
| Dembitz Terry A | Vice President, Administration | filed 2007 - 2007 |
| Groves Eric S | V-P, Project Management | filed 2006 - 2006 |
| Petttit William A | Sr. V-P, HR and Administration | filed 2006 - 2006 |
| Negro-Vilar Andres | Exe V-P, R & D, CSO | filed 2006 - 2006 |
| Crouch Taylor | Sr. V-P, Ops & Pres. Int'l | filed 2006 - 2006 |
| Maier Paul V | Sr. V-P, CFO | filed 2006 - 2006 |
| Broaddus Warner R | V-P, Gen. Counsel & Secy. | filed 2006 - 2006 |
| Litalien James J | Sr. V-P, Reg Affairs & Comp. | filed 2006 - 2006 |
| Mertes TOD | V-P, Controller & Treasurer | filed 2006 - 2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.